How to Buy zimlab Shares on Fincept?
You can buy ZIM Laboratories Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: ZIM Laboratories Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Zimlab, including updates on board meetings and corporate actions.
ZIM Laboratories Limited - https://www.zimlab.in
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
ZIM Laboratories Limited Share Price Today
104.33
OPEN
104.57
HIGH
100.62
LOW
101.27
CLOSE
20 K
VOLUME
535 Cr
Market Cap
169715
Average Volume
Healthcare
Sector
NSI
Exchange
ZIM Laboratories Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: ZIMLAB Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Zim Laboratories Limited |
ZIMLAB |
INE518E01015 |
Annual General Meeting |
20 Jun 2024 |
10 |
N/A |
Zim Laboratories Limited |
ZIMLAB |
INE518E01015 |
Annual General Meeting |
03 Jul 2023 |
10 |
N/A |
Zim Laboratories Limited |
ZIMLAB |
INE518E01015 |
Bonus 2:1 |
22 Dec 2022 |
10 |
N/A |
NSE: ZIMLAB Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
ZIMLAB |
02 Jan 2025, 18:53:37 |
Updates |
N/A |
ZIMLAB |
27 Dec 2024, 16:03:28 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
ZIMLAB |
27 Dec 2024, 16:01:44 |
Loss of Share Certificates |
N/A |
ZIMLAB |
25 Dec 2024, 15:55:41 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
ZIMLAB |
25 Dec 2024, 15:48:42 |
Issue of Duplicate Share Certificate |
N/A |
NSE: ZIMLAB Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Zim Laboratories Limited |
ZIMLAB |
07 Oct 2024, 14:14:00 |
07 Oct 2024, 14:14:00 |
|
Zim Laboratories Limited |
ZIMLAB |
08 Jul 2024, 09:16:00 |
08 Jul 2024, 09:16:00 |
|
Zim Laboratories Limited |
ZIMLAB |
08 Apr 2024, 16:12:00 |
08 Apr 2024, 16:30:00 |
|
Zim Laboratories Limited |
ZIMLAB |
09 Jan 2024, 12:45:00 |
09 Jan 2024, 13:15:00 |
|
Zim Laboratories Limited |
ZIMLAB |
09 Oct 2023, 12:46:00 |
09 Oct 2023, 13:15:00 |
NSE: ZIMLAB Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Executive Director-MD |
31 Dec 1958 |
30 Jun 2002 |
00023529 |
Anwar Daud |
Active |
Executive Director |
27 Aug 1960 |
19 Oct 2012 |
01786763 |
Zulfiquar Murtuza Kamal |
Active |
Executive Director |
07 May 1967 |
22 Nov 2013 |
02007428 |
Niraj Pukhraj Dhadiwal |
Active |
Executive Director |
18 Feb 1968 |
22 Nov 2013 |
02007385 |
Prakash Pralahadrao Sapkal |
Active |
Independent Director |
09 Jan 1971 |
21 Sep 2017 |
07943519 |
Kavita Loya |
Active |
NSE: ZIMLAB Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
ZIMLAB |
N/A |
INE518E01015 |
Zim Laboratories Limited |
04 Nov 2024, 21:08:52 |
ZIM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
ZIMLAB |
N/A |
INE518E01015 |
Zim Laboratories Limited |
27 Jul 2024, 13:07:56 |
ZIM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . |
ZIMLAB |
N/A |
INE518E01015 |
Zim Laboratories Limited |
06 May 2024, 20:00:04 |
ZIM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
ZIMLAB |
N/A |
INE518E01015 |
Zim Laboratories Limited |
22 Jan 2024, 15:05:03 |
Other business matters |
ZIMLAB |
N/A |
INE518E01015 |
Zim Laboratories Limited |
20 Dec 2023, 15:14:03 |
NSE: ZIMLAB Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
ZIMLAB |
- |
INE518E01015 |
Zim Laboratories Limited |
04 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
ZIMLAB |
- |
INE518E01015 |
Zim Laboratories Limited |
27 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results |
ZIMLAB |
- |
INE518E01015 |
Zim Laboratories Limited |
06 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results |
ZIMLAB |
- |
INE518E01015 |
Zim Laboratories Limited |
22 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Other business matters |
ZIMLAB |
- |
INE518E01015 |
Zim Laboratories Limited |
20 Dec 2023, 00:00:00 |
To consider other business matters |
NSE: ZIMLAB Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 48,725,814.00 | 48,725,814.00 | 922,777,000.00 | 1,006,906,000.00 | 2,144,961,000.00 | 3,401,145,000.00 | 610,693,000.00 | 2,144,961,000.00 | 33,379,000.00 | 2,427,618,000.00 | 2,828,636,000.00 | 2,427,624,000.00 | 6,000.00 | 2,427,618,000.00 | 1,940,360,000.00 | 0.00 | 0.00 | 487,258,000.00 | 487,258,000.00 | 1,845,940,000.00 | 540,442,000.00 | 0.00 | 104,169,000.00 | 401,018,000.00 | 0.00 | 401,018,000.00 | 1,305,498,000.00 | 123,228,000.00 | 0.00 | 605,888,000.00 | 33,379,000.00 | 572,509,000.00 | 0.00 | 5,726,000.00 | 478,489,000.00 | 0.00 | 0.00 | 1,263,000.00 | 477,226,000.00 | 4,273,564,000.00 | 2,357,373,000.00 | 50,469,000.00 | 0.00 | 0.00 | 9,121,000.00 | 0.00 | 9,121,000.00 | 0.00 | 282,657,000.00 | 280,963,000.00 | 1,694,000.00 | 1,977,519,000.00 | 0.00 | 1,977,519,000.00 | 333,470,000.00 | 1,644,049,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,916,191,000.00 | 360,900,000.00 | 0.00 | 0.00 | 0.00 | 679,258,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 815,881,000.00 | 0.00 | 0.00 | 60,152,000.00 | 9,402,000.00 | 50,750,000.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 0.00 | 48,725,814.00 | 48,725,814.00 | 966,126,000.00 | 1,116,341,000.00 | 2,160,862,000.00 | 3,449,586,000.00 | 682,233,000.00 | 2,160,862,000.00 | 54,213,000.00 | 2,387,458,000.00 | 2,743,464,000.00 | 2,387,461,000.00 | 3,000.00 | 2,387,458,000.00 | 214,024,000.00 | 1,574,315,000.00 | 80,298,000.00 | 487,258,000.00 | 487,258,000.00 | 2,080,762,000.00 | 486,510,000.00 | 0.00 | 101,009,000.00 | 385,501,000.00 | 29,495,000.00 | 356,006,000.00 | 1,594,252,000.00 | 710,000.00 | 0.00 | 730,840,000.00 | 24,718,000.00 | 706,122,000.00 | 56,451,000.00 | 7,968,000.00 | 706,870,000.00 | 81,569,000.00 | 1,492,000.00 | 0.00 | 623,809,000.00 | 4,468,223,000.00 | 2,191,738,000.00 | 113,599,000.00 | 152,277,000.00 | 0.00 | 515,000.00 | 15,000.00 | 8,370,000.00 | 500,000.00 | 226,596,000.00 | 224,902,000.00 | 1,694,000.00 | 1,804,495,000.00 | -873,076,000.00 | 2,677,571,000.00 | 235,160,000.00 | 186,077,000.00 | 1,305,597,000.00 | 790,029,000.00 | 160,708,000.00 | 0.00 | 2,276,485,000.00 | 3,304,000.00 | 580,000.00 | 11,082,000.00 | 317,255,000.00 | 812,629,000.00 | 269,701,000.00 | 19,717,000.00 | 523,211,000.00 | 33,576,000.00 | 1,001,654,000.00 | -15,195,000.00 | 1,016,849,000.00 | 96,405,000.00 | 403,000.00 | 96,002,000.00 | 96,002,000.00 |
| 2024-03-31T00:00:00 | annual | 0.00 | 48,725,814.00 | 48,725,814.00 | 966,126,000.00 | 1,116,341,000.00 | 2,160,862,000.00 | 3,449,586,000.00 | 682,233,000.00 | 2,160,862,000.00 | 54,213,000.00 | 2,387,458,000.00 | 2,743,464,000.00 | 2,387,461,000.00 | 3,000.00 | 2,387,458,000.00 | 214,024,000.00 | 1,574,315,000.00 | 80,298,000.00 | 487,258,000.00 | 487,258,000.00 | 2,080,762,000.00 | 486,510,000.00 | 0.00 | 101,009,000.00 | 385,501,000.00 | 29,495,000.00 | 356,006,000.00 | 1,594,252,000.00 | 710,000.00 | 0.00 | 730,840,000.00 | 24,718,000.00 | 706,122,000.00 | 56,451,000.00 | 7,968,000.00 | 706,870,000.00 | 81,569,000.00 | 1,492,000.00 | 0.00 | 623,809,000.00 | 4,468,223,000.00 | 2,191,738,000.00 | 113,599,000.00 | 152,277,000.00 | 0.00 | 515,000.00 | 15,000.00 | 8,370,000.00 | 500,000.00 | 226,596,000.00 | 224,902,000.00 | 1,694,000.00 | 1,804,495,000.00 | -873,076,000.00 | 2,677,571,000.00 | 235,160,000.00 | 186,077,000.00 | 1,305,597,000.00 | 790,029,000.00 | 160,708,000.00 | 0.00 | 2,276,485,000.00 | 3,304,000.00 | 580,000.00 | 11,082,000.00 | 317,255,000.00 | 812,629,000.00 | 269,701,000.00 | 19,717,000.00 | 523,211,000.00 | 33,576,000.00 | 1,001,654,000.00 | -15,195,000.00 | 1,016,849,000.00 | 96,405,000.00 | 403,000.00 | 96,002,000.00 | 96,002,000.00 |
| 2023-09-30T00:00:00 | quarterly | 0.00 | 48,725,814.00 | 48,725,814.00 | 453,319,000.00 | 617,397,000.00 | 2,097,317,000.00 | 2,860,914,000.00 | 934,596,000.00 | 2,097,317,000.00 | 16,365,000.00 | 2,259,882,000.00 | 2,638,615,000.00 | 2,259,882,000.00 | 0.00 | 2,259,882,000.00 | 1,772,624,000.00 | 0.00 | 0.00 | 487,258,000.00 | 487,258,000.00 | 1,397,203,000.00 | 436,280,000.00 | 0.00 | 50,821,000.00 | 378,733,000.00 | 0.00 | 378,733,000.00 | 960,923,000.00 | 39,088,000.00 | 0.00 | 238,664,000.00 | 16,365,000.00 | 222,299,000.00 | 0.00 | 6,493,000.00 | 596,125,000.00 | 0.00 | 0.00 | 72,847,000.00 | 523,278,000.00 | 3,657,085,000.00 | 1,761,566,000.00 | 114,226,000.00 | 0.00 | 0.00 | 7,455,000.00 | 0.00 | 7,455,000.00 | 0.00 | 162,565,000.00 | 160,871,000.00 | 1,694,000.00 | 1,452,764,000.00 | 0.00 | 1,452,764,000.00 | 408,901,000.00 | 1,043,863,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,895,519,000.00 | 376,383,000.00 | 0.00 | 0.00 | 0.00 | 660,755,000.00 | 0.00 | 0.00 | 0.00 | 317,000.00 | 683,653,000.00 | 0.00 | 0.00 | 174,411,000.00 | 26,698,000.00 | 147,713,000.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 0.00 | 48,725,814.00 | 48,725,814.00 | 529,897,000.00 | 620,002,000.00 | 1,862,560,000.00 | 2,597,562,000.00 | 801,609,000.00 | 1,862,560,000.00 | 25,900,000.00 | 2,003,460,000.00 | 2,249,705,000.00 | 2,003,460,000.00 | 0.00 | 2,003,460,000.00 | 1,516,202,000.00 | 1,405,670,000.00 | 80,298,000.00 | 487,258,000.00 | 487,258,000.00 | 1,412,326,000.00 | 304,455,000.00 | 0.00 | 48,032,000.00 | 256,423,000.00 | 10,178,000.00 | 246,245,000.00 | 1,107,871,000.00 | 236,000.00 | 0.00 | 363,579,000.00 | 15,722,000.00 | 347,857,000.00 | 61,436,000.00 | 5,949,000.00 | 634,837,000.00 | 50,462,000.00 | 1,985,000.00 | 0.00 | 582,390,000.00 | 3,415,786,000.00 | 1,506,306,000.00 | 117,883,000.00 | 140,132,000.00 | 0.00 | 515,000.00 | 15,000.00 | 9,682,000.00 | 500,000.00 | 140,900,000.00 | 139,206,000.00 | 1,694,000.00 | 1,215,592,000.00 | -744,193,000.00 | 1,959,785,000.00 | 178,385,000.00 | 122,734,000.00 | 994,744,000.00 | 503,214,000.00 | 160,708,000.00 | 0.00 | 1,909,480,000.00 | 6,669,000.00 | 694,000.00 | 11,669,000.00 | 301,332,000.00 | 537,062,000.00 | 90,041,000.00 | 58,845,000.00 | 388,176,000.00 | 34,909,000.00 | 952,487,000.00 | -16,942,000.00 | 969,429,000.00 | 64,658,000.00 | 453,000.00 | 64,205,000.00 | 64,205,000.00 |
| 2023-03-31T00:00:00 | annual | 0.00 | 48,725,814.00 | 48,725,814.00 | 529,897,000.00 | 620,002,000.00 | 1,862,560,000.00 | 2,597,562,000.00 | 801,609,000.00 | 1,862,560,000.00 | 25,900,000.00 | 2,003,460,000.00 | 2,249,705,000.00 | 2,003,460,000.00 | 0.00 | 2,003,460,000.00 | 1,516,202,000.00 | 1,405,670,000.00 | 80,298,000.00 | 487,258,000.00 | 487,258,000.00 | 1,412,326,000.00 | 304,455,000.00 | 0.00 | 48,032,000.00 | 256,423,000.00 | 10,178,000.00 | 246,245,000.00 | 1,107,871,000.00 | 236,000.00 | 0.00 | 363,579,000.00 | 15,722,000.00 | 347,857,000.00 | 61,436,000.00 | 5,949,000.00 | 634,837,000.00 | 50,462,000.00 | 1,985,000.00 | 0.00 | 582,390,000.00 | 3,415,786,000.00 | 1,506,306,000.00 | 117,883,000.00 | 140,132,000.00 | 0.00 | 515,000.00 | 15,000.00 | 9,682,000.00 | 500,000.00 | 140,900,000.00 | 139,206,000.00 | 1,694,000.00 | 1,215,592,000.00 | -744,193,000.00 | 1,959,785,000.00 | 178,385,000.00 | 122,734,000.00 | 994,744,000.00 | 503,214,000.00 | 160,708,000.00 | 0.00 | 1,909,480,000.00 | 6,669,000.00 | 694,000.00 | 11,669,000.00 | 301,332,000.00 | 537,062,000.00 | 90,041,000.00 | 58,845,000.00 | 388,176,000.00 | 34,909,000.00 | 952,487,000.00 | -16,942,000.00 | 969,429,000.00 | 64,658,000.00 | 453,000.00 | 64,205,000.00 | 64,205,000.00 |
| 2022-03-31T00:00:00 | annual | 0.00 | 48,725,814.00 | 48,725,814.00 | 477,636,000.00 | 533,136,000.00 | 1,651,907,000.00 | 2,268,934,000.00 | 662,267,000.00 | 1,651,907,000.00 | 21,297,000.00 | 1,757,095,000.00 | 1,946,329,000.00 | 1,757,095,000.00 | 0.00 | 1,757,095,000.00 | 0.00 | 1,165,941,000.00 | 409,887,000.00 | 162,419,000.00 | 162,419,000.00 | 1,659,189,000.00 | 200,090,000.00 | 0.00 | 3,633,000.00 | 196,457,000.00 | 7,223,000.00 | 189,234,000.00 | 1,459,099,000.00 | 430,000.00 | 20,656,000.00 | 336,679,000.00 | 14,074,000.00 | 322,605,000.00 | 35,457,000.00 | 0.00 | 841,673,000.00 | 28,394,000.00 | 2,570,000.00 | 0.00 | 810,709,000.00 | 3,416,284,000.00 | 1,294,918,000.00 | 0.00 | 104,978,000.00 | 0.00 | 515,000.00 | 15,000.00 | 0.00 | 500,000.00 | 105,188,000.00 | 103,494,000.00 | 1,694,000.00 | 1,068,649,000.00 | -630,086,000.00 | 1,698,735,000.00 | 50,974,000.00 | 88,201,000.00 | 927,452,000.00 | 471,400,000.00 | 160,708,000.00 | 0.00 | 2,121,366,000.00 | 3,855,000.00 | 0.00 | 17,652,000.00 | 334,739,000.00 | 752,842,000.00 | 186,927,000.00 | 126,594,000.00 | 439,321,000.00 | 82,868,000.00 | 895,207,000.00 | -9,028,000.00 | 904,235,000.00 | 34,203,000.00 | 0.00 | 34,203,000.00 | 34,203,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 48,725,814.00 | 48,725,814.00 | 796,775,000.00 | 823,197,000.00 | 1,487,846,000.00 | 2,418,200,000.00 | 497,247,000.00 | 1,487,846,000.00 | 12,497,000.00 | 1,607,500,000.00 | 1,825,792,000.00 | 1,607,500,000.00 | 0.00 | 1,607,500,000.00 | 1,445,181,000.00 | 1,019,981,000.00 | 409,887,000.00 | 162,419,000.00 | 162,419,000.00 | 1,640,322,000.00 | 219,967,000.00 | -110,000.00 | 0.00 | 219,967,000.00 | 1,675,000.00 | 218,292,000.00 | 1,420,355,000.00 | 188,000.00 | 0.00 | 603,230,000.00 | 10,822,000.00 | 592,408,000.00 | 48,398,000.00 | 14,038,000.00 | 680,610,000.00 | 27,652,000.00 | 4,248,000.00 | 0.00 | 648,710,000.00 | 3,247,822,000.00 | 1,330,220,000.00 | 56,615,000.00 | 104,595,000.00 | 26,064,000.00 | 515,000.00 | 15,000.00 | 27,525,000.00 | 500,000.00 | 119,654,000.00 | 117,960,000.00 | 1,694,000.00 | 1,052,382,000.00 | -505,163,000.00 | 1,557,545,000.00 | 45,613,000.00 | 64,373,000.00 | 856,709,000.00 | 436,390,000.00 | 154,460,000.00 | 0.00 | 1,917,602,000.00 | 469,220,000.00 | 0.00 | 72,170,000.00 | 469,220,000.00 | 543,472,000.00 | 109,472,000.00 | 107,359,000.00 | 326,641,000.00 | 96,302,000.00 | 722,513,000.00 | -9,028,000.00 | 731,541,000.00 | 13,925,000.00 | 167,652,000.00 | 13,925,000.00 | 13,925,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,578,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53,281,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: ZIMLAB Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -576,450,000.00 | -129,325,000.00 | 281,469,000.00 | 214,024,000.00 | -739,232,000.00 | 96,002,000.00 | 0.00 | 64,205,000.00 | 3,801,000.00 | 27,996,000.00 | 595,340,000.00 | 493,000.00 | -75,136,000.00 | -493,000.00 | 0.00 | 214,024,000.00 | 214,024,000.00 | 473,691,000.00 | 321,547,000.00 | 321,547,000.00 | 152,144,000.00 | -129,325,000.00 | 281,469,000.00 | -730,126,000.00 | 0.00 | 433,000.00 | 60,000.00 | 3,132,000.00 | 5,971,000.00 | -2,839,000.00 | 0.00 | 0.00 | -733,751,000.00 | 5,481,000.00 | -739,232,000.00 | 0.00 | 162,782,000.00 | -25,844,000.00 | -267,851,000.00 | 79,081,000.00 | -275,567,000.00 | -71,365,000.00 | 67,434,000.00 | 0.00 | -1,747,000.00 | 159,518,000.00 | 28,595,000.00 | 130,923,000.00 | -4,000.00 | -60,000.00 | -11,398,000.00 | -4,697,000.00 | 236,424,000.00 |
| 2023-03-31T00:00:00 | annual | 15,003,000.00 | -154,708,000.00 | 183,530,000.00 | 0.00 | -366,679,000.00 | 64,205,000.00 | 0.00 | 34,203,000.00 | 4,899,000.00 | 25,103,000.00 | 5,456,000.00 | 585,000.00 | -55,335,000.00 | -585,000.00 | 0.00 | 0.00 | 0.00 | 84,738,000.00 | 55,916,000.00 | 55,916,000.00 | 28,822,000.00 | -154,708,000.00 | 183,530,000.00 | -362,035,000.00 | 3,599,000.00 | 785,000.00 | 60,000.00 | 3,599,000.00 | 3,599,000.00 | 0.00 | 0.00 | 0.00 | -366,479,000.00 | 200,000.00 | -366,679,000.00 | 0.00 | 381,682,000.00 | -71,485,000.00 | -121,933,000.00 | -364,659,000.00 | 215,780,000.00 | 26,946,000.00 | 53,331,000.00 | 0.00 | 7,914,000.00 | 174,690,000.00 | 0.00 | 174,690,000.00 | -10,546,000.00 | -60,000.00 | -10,176,000.00 | -200,000.00 | 353,550,000.00 |
| 2022-03-31T00:00:00 | annual | 339,808,000.00 | -299,300,000.00 | 270,701,000.00 | 0.00 | -152,253,000.00 | 34,203,000.00 | 0.00 | 13,925,000.00 | 3,635,000.00 | 16,643,000.00 | -329,705,000.00 | 65,879,000.00 | -79,264,000.00 | -1,678,000.00 | 0.00 | 0.00 | 0.00 | -302,384,000.00 | -273,785,000.00 | 0.00 | -28,599,000.00 | -299,300,000.00 | 270,701,000.00 | -145,713,000.00 | 2,995,000.00 | 1,885,000.00 | 60,000.00 | 2,995,000.00 | 2,995,000.00 | 0.00 | 0.00 | 0.00 | -150,653,000.00 | 1,600,000.00 | -152,253,000.00 | 0.00 | 492,061,000.00 | -4,291,000.00 | 65,806,000.00 | 295,073,000.00 | -209,370,000.00 | -19,897,000.00 | 79,688,000.00 | 0.00 | 0.00 | 160,331,000.00 | 0.00 | 160,331,000.00 | -10,082,000.00 | -60,000.00 | -9,763,000.00 | -570,000.00 | 210,425,000.00 |
| 2021-03-31T00:00:00 | annual | 253,742,000.00 | -234,945,000.00 | 191,677,000.00 | 612,000.00 | -64,771,000.00 | 13,925,000.00 | 0.00 | 14,610,000.00 | -647,000.00 | -38,000.00 | -259,742,000.00 | -48,621,000.00 | -102,659,000.00 | -244,000.00 | 0.00 | 612,000.00 | 612,000.00 | -94,890,000.00 | -51,622,000.00 | 0.00 | -43,268,000.00 | -234,945,000.00 | 191,677,000.00 | -58,809,000.00 | 1,973,000.00 | 3,930,000.00 | 0.00 | 1,973,000.00 | 1,973,000.00 | 0.00 | 0.00 | 0.00 | -64,712,000.00 | 59,000.00 | -64,771,000.00 | 0.00 | 318,513,000.00 | -11,127,000.00 | -82,409,000.00 | 26,323,000.00 | 20,419,000.00 | -129,151,000.00 | 103,965,000.00 | 0.00 | 0.00 | 157,890,000.00 | 0.00 | 157,890,000.00 | -1,987,000.00 | 0.00 | -8,561,000.00 | -60,000.00 | 154,120,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7,448,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3,311,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -19,467,000.00 | -500,000.00 | -500,000.00 | 0.00 | 0.00 | 0.00 | -185,277,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 152,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -60,000.00 | 0.00 | 0.00 | 0.00 |
NSE: ZIMLAB Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Impairment Of Capital Assets | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -0.30 | 0.00 | 46.59 | -1.12 | -1.12 | 17.25 | 15.95 | 172.37 | 45.48 | 29.52 | -6.79 | 5.88 | 0.13 | 18.06 | 17.25 | 328.75 | 0.21 | 4.87 | 4.87 | 0.00 | 0.00 | 17.25 | 17.25 | 0.00 | 17.25 | 0.00 | 17.25 | 17.25 | 6.40 | 23.64 | 0.97 | -1.12 | 0.02 | 1.10 | 0.00 | -6.79 | 1.04 | 5.88 | 0.13 | 26.77 | 156.37 | 42.20 | 15.95 | 2.86 | 13.09 | 35.73 | 24.48 | 11.25 | 0.21 | 183.14 | 172.37 | 355.51 | 355.51 |
| 2023-03-31T00:00:00 | annual | -0.20 | 0.00 | 58.45 | -0.66 | -0.66 | 24.43 | 17.47 | 199.94 | 57.79 | 40.33 | -5.24 | 4.97 | 0.34 | 24.89 | 24.43 | 353.47 | 0.22 | 4.87 | 4.87 | 0.00 | 0.00 | 24.43 | 24.43 | 0.00 | 24.43 | 0.00 | 24.43 | 24.43 | 10.92 | 35.36 | 0.44 | -0.66 | 0.00 | 0.00 | 0.66 | -5.24 | 0.61 | 4.97 | 0.34 | 35.26 | 153.53 | 37.54 | 17.47 | 4.00 | 13.47 | 41.06 | 27.94 | 13.12 | 0.22 | 188.79 | 199.94 | 388.73 | 388.73 |
| 2022-03-31T00:00:00 | annual | -0.02 | 0.00 | 44.30 | -0.06 | -0.06 | 14.55 | 16.03 | 161.24 | 44.24 | 28.21 | -8.02 | 7.17 | 0.28 | 14.59 | 14.55 | 303.16 | 0.51 | 4.87 | 4.87 | 0.00 | 0.00 | 14.55 | 14.55 | 0.00 | 14.55 | 0.00 | 14.55 | 14.55 | 6.49 | 21.04 | 0.18 | -0.06 | 0.00 | 0.05 | 0.00 | -8.02 | 1.14 | 7.17 | 0.28 | 25.09 | 141.92 | 29.78 | 16.03 | 3.14 | 12.90 | 44.58 | 32.70 | 11.89 | 0.51 | 167.00 | 161.24 | 328.25 | 328.25 |
| 2021-03-31T00:00:00 | annual | -1.67 | 0.00 | 41.38 | -5.85 | -5.85 | 7.32 | 15.79 | 159.25 | 35.53 | 19.74 | -10.21 | 9.51 | 0.69 | 11.50 | 7.32 | 267.24 | 0.29 | 4.87 | 4.87 | 0.00 | 0.00 | 7.32 | 7.32 | 0.00 | 7.32 | 0.00 | 7.32 | 7.32 | 2.91 | 10.23 | 0.17 | -5.85 | 0.00 | 5.85 | 0.00 | -10.21 | 1.39 | 9.51 | 0.69 | 24.72 | 107.99 | 21.61 | 15.79 | 3.05 | 12.74 | 36.40 | 27.96 | 8.44 | 0.29 | 132.71 | 159.25 | 291.97 | 291.97 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
3.31
P/E
32.848946
P/B
2.2190702
Dividend Yield
N/A
Market Cap
534.57 Cr.
Face Value
48.998
Book Value
48.998
ROE
4.69%
EBITDA Growth
41.04 Cr.
Debt/Equity
46.817
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of zimlab?
The market capitalization of ZIM Laboratories Limited is ₹535 Cr as of 05 Feb 2025.
What are the PE and PB ratios of ZIM Laboratories Limited?
The PE and PB ratios of ZIM Laboratories Limited are Not Available and 2.2190702 respectively as of 05 Feb 2025.
What is the 52 Week High of ZIM Laboratories Limited?
The 52-week high of ZIM Laboratories Limited is ₹131.4 as of 05 Feb 2025.
What is the 52 Week Low of ZIM Laboratories Limited?
The 52-week low of ZIM Laboratories Limited is ₹89.5 as of 05 Feb 2025.
What are the earnings per share (EPS) for ZIM Laboratories Limited?
The Earnings Per Share (EPS) of ZIM Laboratories Limited is ₹3.31 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of ZIM Laboratories Limited?
The Return on Equity (ROE) of ZIM Laboratories Limited is 4.69% as per the most recent financial year data. Explore more on Fincept.